Botanical species · safety record

Liquidambar orientalis

The EFSA Compendium of Botanicals holds 10 constituent measurements for Liquidambar orientalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Liquidambar orientalis Mill.

10Constituent measurements
0Safety records
4Cited sources
7Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 7 licensed products naming Liquidambar orientalis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Balsam
  • Gum resin from bark
  • Stem bark resin

What the records describe

Constituents measured

  • P-coumaric acid3
  • Cinnamyl alcohol2
  • Gallic acid2
  • 3,4-dihydroxybenzoic acid1
  • Benzaldehyde1
  • Proanthocyanidins (condensed tannins)1

Plant parts

  • Leaves5
  • Trunk3
  • Aerial part of plants2

Preparations

  • Solvent extraction7
  • Raw, no heat treatment1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
3,4-dihydroxybenzoic acidLeavesSolvent extraction12.232 Milligram/gramUnspecifiedResolve DOI
BenzaldehydeLeavesSolvent extraction2.203 PercentGC-MSResolve DOI
Cinnamyl alcoholAerial part of plants34.3 PercentResolve DOI
Cinnamyl alcoholAerial part of plants54.7 PercentResolve DOI
Gallic acidLeavesSolvent extraction3.258 Milligram/gramUnspecifiedResolve DOI
Gallic acidTrunkSolvent extraction1.6 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
P-coumaric acidLeavesSolvent extractionUnspecifiedResolve DOI
P-coumaric acidTrunkRaw, no heat treatment2.95 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
P-coumaric acidTrunkSolvent extraction11.46 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Proanthocyanidins (condensed tannins)LeavesSolvent extraction9.29 PercentUnspecifiedResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Charehsaz, Mohammad., Reis, Rengin., Helvacioglu, Sinem., Sipahi, Hande., Guzelmeric, Etil., Acar, Ebru Turkoz., Cicek, Gamze., Yesilada, Erdem., Aydin, Ahmet. Safety evaluation of styrax liquidus from the viewpoint of genotoxicity and mutagenicity . Journal of ethnopharmacology, 2016, vol. 194, p. 506-512. DOI
  2. Ma, Li., Li, Weilin., Qin, Luping., Yao, Shun., Sung, WP., Zhang, CZ., Chen, R. Identification of Volatile Components in Grafted Liquidambar Orientalis Mill. . Biotechnology, chemical and materials engineering ii, pts 1 and 2, 2013, vol. 641-642, p. 773-+. DOI
  3. Kim, Junheon., Jang, Miyeon., Shin, Eunsik., Kim, Jeongmin., Lee, Si Hyeock., Park, Chung Gyoo. Fumigant and contact toxicity of 22 wooden essential oils and their major components against Drosophila suzukii (Diptera: Drosophilidae) . Pesticide biochemistry and physiology, 2016, vol. 133, p. 35-43. DOI
  4. Ulger, Ismail., Kamalak, Adem., Kurt, Ozer., Kaya, Emrah., Guven, Inan. Comparison of the chemical composition and anti-methanogenic potential of Liquidambar orientalis leaves with Laurus nobilis and Eucalyptus globulus leaves using an in vitro gas production technique . Ciencia e investigacion agraria, 2017, vol. 44, no. 1, p. 75-82. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue